Is AMBU B undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
1/6
Valuation Score 1/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of AMBU B when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: AMBU B (DKK106.15) is trading below our estimate of fair value (DKK106.21)
Significantly Below Fair Value: AMBU B is trading below fair value, but not by a significant amount.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for AMBU B?
Key metric: As AMBU B is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.
The above table shows the Price to Earnings ratio for AMBU B. This is calculated by dividing AMBU B's market cap by their current
earnings.
What is AMBU B's PE Ratio?
PE Ratio
120.3x
Earnings
DKK 235.00m
Market Cap
DKK 28.28b
AMBU B key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Price-To-Earnings vs Industry: AMBU B is expensive based on its Price-To-Earnings Ratio (120.3x) compared to the European Medical Equipment industry average (29.6x).
Price to Earnings Ratio vs Fair Ratio
What is AMBU B's PE Ratio
compared to its
Fair PE Ratio?
This is the expected PE Ratio taking into
account the company's forecast earnings growth, profit margins
and other risk factors.
AMBU B PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio
120.3x
Fair PE Ratio
42x
Price-To-Earnings vs Fair Ratio: AMBU B is expensive based on its Price-To-Earnings Ratio (120.3x) compared to the estimated Fair Price-To-Earnings Ratio (42x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
The above table shows the analyst AMBU B forecast and predictions for the stock price in 12 month’s time.
Date
Share Price
Average 1Y Price Target
Dispersion
High
Low
1Y Actual price
Analysts
Current
DKK 106.15
DKK 127.70
+20.3%
18.5%
DKK 160.00
DKK 76.00
n/a
7
Dec ’25
DKK 111.00
DKK 127.63
+15.0%
18.5%
DKK 160.00
DKK 76.00
n/a
7
Nov ’25
DKK 129.70
DKK 128.67
-0.8%
18.5%
DKK 145.00
DKK 76.00
n/a
6
Oct ’25
DKK 130.00
DKK 125.50
-3.5%
19.1%
DKK 145.00
DKK 76.00
n/a
6
Sep ’25
DKK 127.95
DKK 126.40
-1.2%
21.9%
DKK 160.00
DKK 76.00
n/a
5
Aug ’25
DKK 140.60
DKK 117.00
-16.8%
25.0%
DKK 138.00
DKK 59.00
n/a
5
Jul ’25
DKK 136.55
DKK 117.00
-14.3%
25.0%
DKK 138.00
DKK 59.00
n/a
5
Jun ’25
DKK 131.40
DKK 111.20
-15.4%
24.9%
DKK 138.00
DKK 59.00
n/a
5
May ’25
DKK 111.95
DKK 107.20
-4.2%
26.4%
DKK 130.00
DKK 52.00
n/a
5
Apr ’25
DKK 113.55
DKK 107.20
-5.6%
26.4%
DKK 130.00
DKK 52.00
n/a
5
Mar ’25
DKK 121.45
DKK 107.20
-11.7%
26.4%
DKK 130.00
DKK 52.00
n/a
5
Feb ’25
DKK 111.60
DKK 105.00
-5.9%
26.7%
DKK 130.00
DKK 52.00
n/a
5
Jan ’25
DKK 105.20
DKK 85.67
-18.6%
26.2%
DKK 115.00
DKK 47.00
n/a
6
Dec ’24
DKK 91.94
DKK 85.67
-6.8%
26.2%
DKK 115.00
DKK 47.00
DKK 111.00
6
Nov ’24
DKK 69.86
DKK 89.40
+28.0%
28.2%
DKK 120.00
DKK 53.00
DKK 129.70
5
Oct ’24
DKK 73.86
DKK 95.60
+29.4%
25.6%
DKK 120.00
DKK 53.00
DKK 130.00
5
Sep ’24
DKK 83.56
DKK 96.00
+14.9%
25.3%
DKK 120.00
DKK 53.00
DKK 127.95
5
Aug ’24
DKK 99.16
DKK 101.80
+2.7%
27.0%
DKK 135.00
DKK 59.00
DKK 140.60
5
Jul ’24
DKK 111.65
DKK 102.60
-8.1%
26.9%
DKK 135.00
DKK 59.00
DKK 136.55
5
Jun ’24
DKK 107.50
DKK 102.60
-4.6%
26.9%
DKK 135.00
DKK 59.00
DKK 131.40
5
May ’24
DKK 105.50
DKK 101.60
-3.7%
28.4%
DKK 135.00
DKK 55.00
DKK 111.95
5
Apr ’24
DKK 102.75
DKK 96.25
-6.3%
30.8%
DKK 135.00
DKK 55.00
DKK 113.55
4
Mar ’24
DKK 101.35
DKK 104.60
+3.2%
30.2%
DKK 140.00
DKK 55.00
DKK 121.45
5
Feb ’24
DKK 99.14
DKK 87.80
-11.4%
20.6%
DKK 110.00
DKK 65.00
DKK 111.60
5
Jan ’24
DKK 89.00
DKK 83.40
-6.3%
19.5%
DKK 110.00
DKK 65.00
DKK 105.20
5
Dec ’23
DKK 91.70
DKK 83.20
-9.3%
19.8%
DKK 110.00
DKK 64.00
DKK 91.94
5
Analyst Forecast: Target price is more than 20% higher than the current share price, but analysts are not within a statistically confident range of agreement.
Discover undervalued companies
7D
1Y
7D
1Y
7D
1Y
Company Analysis and Financial Data Status
Data
Last Updated (UTC time)
Company Analysis
2024/12/24 01:11
End of Day Share Price
2024/12/23 00:00
Earnings
2024/09/30
Annual Earnings
2024/09/30
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Ambu A/S is covered by 16 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.